At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 20 enrolled
Drug / intervention
Licensed seasonal influenza vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Extent and Durability of Immune Response Following Seasonal Influenza Vaccination in Healthy Volunteers
In Brief
A Phase 4 clinical trial evaluating Licensed seasonal influenza vaccine for Influenza. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This is an open-label, single administration dose study in adult healthy male and female subjects. After qualifying for the study, subjects will receive a single intramuscular injection of the FDA approved 2016-2017 quadrivalent influenza vaccine.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States
CollaboratorsOptimal Health Research
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedMay 2017
Primary CompletionNov 2017
Study CompletionJun 2018
TodayJul 2026
First PostedMay 23, 2017
Enrollment StartMay 8, 2017
Primary CompletionNov 21, 2017
Study CompletionJun 15, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.1 years ago
Interventions
Licensed seasonal influenza vaccinebiological
20 healthy subjects will be enrolled and receive a single dose of licensed seasonal influenza vaccine